Disclosed positions

Estimated from their latest filings — positions may have changed since

$193.80M

combined est. value

Stock	Shares	Price	Value	Weight	As of
LQDALiquidia Corp	2,200,967	$81.45	$179.27M	93%	2026-05-26
AXSMAxsome Therapeutics, Inc.	58,367	$248.95	$14.53M	7%	2026-06-11

LQDA

Liquidia Corp

$179.27M

2,200,967 sh

AXSM

Axsome Therapeutics, Inc.

$14.53M

58,367 sh

All filings on record

Every Form 4 transaction we track for this filer

all 27buys 0sells 19

Stock	Transaction	Date	~6mo later
AXSMAxsome Therapeutics, Inc.	Sell $71.2K · 286 sh	2026-06-11	—
AXSMAxsome Therapeutics, Inc.	Sell $70.4K · 286 sh	2026-06-10	—
AXSMAxsome Therapeutics, Inc.	Exercise — · 1,429 sh	2026-06-08	—
LQDALiquidia Corp	Sell $1.51M · 25,000 sh	2026-05-26	—
LQDALiquidia Corp	Sell $1.54M · 25,000 sh	2026-05-22	—
LQDALiquidia Corp	Sell $1.53M · 25,000 sh	2026-05-21	—
LQDALiquidia Corp	Sell $1.53M · 25,000 sh	2026-05-20	—
LQDALiquidia Corp	Sell $1.47M · 25,000 sh	2026-05-19	—
LQDALiquidia Corp	Sell $1.42M · 25,000 sh	2026-05-18	—
LQDALiquidia Corp	Grant — · 115,344 sh	2026-01-16	—
LQDALiquidia Corp	Sell $2.49M · 66,610 sh	2026-01-12	—
LQDALiquidia Corp	Exercise — · 57,332 sh	2026-01-09	—
LQDALiquidia Corp	Exercise — · 13,833 sh	2026-01-09	—
LQDALiquidia Corp	Sell $474.3K · 20,261 sh	2025-10-13	—
LQDALiquidia Corp	Exercise — · 13,834 sh	2025-10-10	—
AXSMAxsome Therapeutics, Inc.	Sell $1.67M · 13,464 sh	2025-09-02	—
AXSMAxsome Therapeutics, Inc.	Sell $2.43M · 20,000 sh	2025-08-29	—
AXSMAxsome Therapeutics, Inc.	Sell $2.43M · 20,000 sh	2025-08-28	—
AXSMAxsome Therapeutics, Inc.	Sell $2.45M · 20,000 sh	2025-08-27	—
AXSMAxsome Therapeutics, Inc.	Sell $2.40M · 20,000 sh	2025-08-26	—
AXSMAxsome Therapeutics, Inc.	Sell $2.00M · 16,694 sh	2025-08-22	—
LQDALiquidia Corp	Sell $289.2K · 20,252 sh	2025-07-14	—
LQDALiquidia Corp	Sell $289.2K · 20,252 sh	2025-07-14	—
LQDALiquidia Corp	Exercise — · 13,833 sh	2025-07-11	—
LQDALiquidia Corp	Exercise — · 13,833 sh	2025-07-11	—

AXSMSell

2026-06-11 · Axsome Therapeutics, Inc.

$71.2K

—

AXSMSell

2026-06-10 · Axsome Therapeutics, Inc.

$70.4K

—

AXSMExercise

2026-06-08 · Axsome Therapeutics, Inc.

1,429

—

LQDASell

2026-05-26 · Liquidia Corp

$1.51M

—

LQDASell

2026-05-22 · Liquidia Corp

$1.54M

—

LQDASell

2026-05-21 · Liquidia Corp

$1.53M

—

LQDASell

2026-05-20 · Liquidia Corp

$1.53M

—

LQDASell

2026-05-19 · Liquidia Corp

$1.47M

—

LQDASell

2026-05-18 · Liquidia Corp

$1.42M

—

LQDAGrant

2026-01-16 · Liquidia Corp

115,344

—

LQDASell

2026-01-12 · Liquidia Corp

$2.49M

—

LQDAExercise

2026-01-09 · Liquidia Corp

57,332

—

LQDAExercise

2026-01-09 · Liquidia Corp

13,833

—

LQDASell

2025-10-13 · Liquidia Corp

$474.3K

—

LQDAExercise

2025-10-10 · Liquidia Corp

13,834

—

AXSMSell

2025-09-02 · Axsome Therapeutics, Inc.

$1.67M

—

AXSMSell

2025-08-29 · Axsome Therapeutics, Inc.

$2.43M

—

AXSMSell

2025-08-28 · Axsome Therapeutics, Inc.

$2.43M

—

AXSMSell

2025-08-27 · Axsome Therapeutics, Inc.

$2.45M

—

AXSMSell

2025-08-26 · Axsome Therapeutics, Inc.

$2.40M

—

AXSMSell

2025-08-22 · Axsome Therapeutics, Inc.

$2.00M

—

LQDASell

2025-07-14 · Liquidia Corp

$289.2K

—

LQDASell

2025-07-14 · Liquidia Corp

$289.2K

—

LQDAExercise

2025-07-11 · Liquidia Corp

13,833

—

LQDAExercise

2025-07-11 · Liquidia Corp

13,833

—

Show all 27 filings

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.